Jommi, Claudio, and Roberto Ravasio. “The Value of Obinutuzumab for Untreated Advanced Follicular Lymphoma: An Assessment Based on Multicriteria Decision Analysis (MCDA)”. AboutOpen 6, no. 1 (November 21, 2019): 78–85. Accessed April 25, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/302.